Drugs / Foster
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT02127866 | Apr 2014 → Mar 2015 | asthma | Chiesi Farmaceutici S.p.A. | Completed | Met primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT04185129 | Jan 2020 → Dec 2021 | asthma | Far Eastern Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Foster | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02127866 ↗ |